Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
172.62
-1.36 (-0.78%)
At close: Nov 11, 2026, 4:00 PM EST
169.01
-3.61 (-2.09%)
Pre-market: Nov 12, 2026, 9:00 AM EST
Repligen Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Repligen stock has a consensus rating of "Buy" and an average price target of $203.21. The average 1-year stock price forecast is 17.72% higher than the current stock price, while the lowest is $175 (+1.38%) and the highest is $235 (+36.14%).
Price Target: $203.21 (+17.72%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Repligen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 15 | 15 | 15 | 13 | 13 |
| Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Hold | 4 | 3 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 22 | 22 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $207 | Buy | Maintains | $207 | +19.92% | Nov 11, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $200 | Buy | Maintains | $200 | +15.86% | Nov 2, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $200 → $205 | Buy | Maintains | $200 → $205 | +18.76% | Oct 30, 2026 |
| KeyBanc | KeyBanc | Buy Maintains $220 | Buy | Maintains | $220 | +27.45% | Oct 29, 2026 |
| UBS | UBS | Buy Maintains $235 | Buy | Maintains | $235 | +36.14% | Oct 28, 2026 |
Financial Forecast
Revenue This Year
848.82M
from 738.26M
Increased by 14.98%
Revenue Next Year
1.07B
from 848.82M
Increased by 26.05%
EPS This Year
2.07
from 1.71
Increased by 21.25%
EPS Next Year
2.65
from 2.07
Increased by 27.91%
EPS and Forward PE are based on non-GAAP adjusted numbers.